Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hepatitis C
ADR ID BADD_A02025
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.09      Hepatic viral infections
09.01.09.005      Hepatitis C
11      Infections and infestations
11.05      Viral infectious disorders
11.05.06      Hepatitis viral infections
11.05.06.004      Hepatitis C
Description INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. [MeSH]
MedDRA Code 10019744
MeSH ID D006526
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute or unspecified hepatitis C with hepatic coma | Acute or unspecified hepatitis C without mention of hepatic coma | Biphasic hepatitis | Hepatitis C | Viral hepatitis C | HCV coinfection | Hepatitis C aggravated | Hepatitis C recurrent | Hepatitis C relapse | Parenterally-Transmitted Non-A, Non-B Hepatitis | Parenterally Transmitted Non A, Non B Hepatitis | PT-NANBH | Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01242Lamivudine0.013914%
BADD_D01253Lenalidomide--
BADD_D01281Levonorgestrel--
BADD_D01303Lithium carbonate0.000818%
BADD_D01336Macitentan--
BADD_D01418Methotrexate0.003920%
BADD_D01507Mycophenolate mofetil0.003269%
BADD_D01508Mycophenolic acid0.001737%
BADD_D01527Naltrexone--
BADD_D01567Nilotinib0.001865%
BADD_D01645Oxycodone0.000139%
BADD_D01654Palbociclib--
BADD_D01656Paliperidone--
BADD_D01798Pomalidomide--
BADD_D01834Prednisone--
BADD_D01835Pregabalin--
BADD_D01858Propagermanium--
BADD_D01864Propofol0.000788%
BADD_D01906Raltegravir potassium--
BADD_D01933Ribavirin0.569942%
BADD_D01940Rilpivirine--
BADD_D01954Rivaroxaban--
BADD_D01978Ruxolitinib--
BADD_D02028Sirolimus0.000686%
BADD_D02053Sofosbuvir0.254608%
BADD_D02058Sorafenib--
BADD_D02100Sunitinib--
BADD_D02105Tacrolimus0.019162%
BADD_D02192Thalidomide0.001737%
BADD_D02236Tofacitinib--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages